• John H McDermott and William G Newman.
• Manchester Centre for Genomic Medicine, Manchester, UK and University of Manchester, Manchester, UK john.mcdermott2@mft.nhs.uk.
• Clin Med (Lond). 2020 Sep 1; 20 (5): e163e164e163-e164.

AbstractWidespread testing for the respiratory syndrome coronavirus-2 (SARS-CoV-2) will represent an important part of any strategy designed to safely reopen societies from lockdown. Healthcare settings have the potential to become reservoirs of infectivity, and therefore many hospital trusts are beginning to carry out routine screening of staff and patients. This could promote the effective cohorting of patients and reduce the rate of nosocomial infection. However, for various reasons, some individuals may refuse this testing. Here we highlight this as an emergent ethicolegal issue which we expect to become increasingly relevant as testing becomes ubiquitous. We explore this position from an ethical and legal perspective, determining whether refusal of testing is acceptable under UK law. Individual patients refusing testing could undermine a hospital's testing strategy; therefore clinicians and policy makers must prospectively determine the best course of action if this were to occur.© Royal College of Physicians 2020. All rights reserved.

31 keywords...

hide…